Latent TB Testing Market Size, Share, Trends, Industry Analysis Report: By Test Type (IGRA and TST), Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Description

List of Tables

The latent TB testing market size is expected to reach USD 1,005.69 million by 2034, according to a new study by Polaris Market Research. The report "Latent TB Testing Market Share, Size, Trends, Industry Analysis Report: By Test Type (IGRA and TST), Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Latent TB testing refers to diagnostic procedures used to identify tuberculosis (TB) infection in asymptomatic individuals before it progresses to active disease. One of the key latent TB testing market trends is the shift toward high-precision, laboratory-based diagnostics, particularly with the increasing adoption of Interferon-Gamma Release Assays (IGRAs). These advanced testing methods offer improved accuracy and eliminate the need for multiple patient visits, improving compliance and efficiency in large-scale screening programs. Additionally, continuous advancements in molecular diagnostics and automation are streamlining testing workflows, reducing turnaround times, and increasing the reliability of results. The growing demand for such innovations underscores the market's emphasis on precision and operational efficiency in TB detection.

Another major trend shaping the latent TB testing market growth is the expansion of preventive screening programs driven by heightened awareness and policy initiatives. Governments, healthcare organizations, and nonprofit entities are actively promoting early detection strategies to curb the global TB burden, particularly in high-risk populations. The integration of TB screening into routine healthcare check-ups, occupational health programs, and immunosuppressive therapy monitoring has accelerated testing adoption. Additionally, strategic collaborations between diagnostic firms and public health agencies are improving accessibility to reliable testing solutions. This increasing focus on preventive care highlights the market's evolution toward proactive tuberculosis management, reinforcing the critical role of early and accurate diagnosis.

Latent TB Testing Market Report Highlights

In terms of test type, the IGRA segment dominated the latent TB testing market share in 2024, due to its higher accuracy, reliability, and efficiency compared to the traditional Tuberculin Skin Test (TST).

Based on end user, the hospitals and clinics segment is expected to witness the fastest growth, driven by their role as primary providers for routine screenings and diagnostic services.

North America dominated the latent TB testing market revenue in 2024, supported by robust healthcare infrastructure, high awareness, and extensive screening programs.

The Asia Pacific market is projected to experience the fastest market growth, fueled by the rising TB burden and increasing focus on early detection strategies.

A few global key market players include QIAGEN; Revvity; Beijing Wantai Biopharmaceutical Co., Ltd.; Sanofi; Endo, Inc.; bioMerieux; SD Biosensor, INC.; Lionex GmbH; Serum Institute of India Pvt. Ltd.; ARKRAY, Inc.; Zhi Fei Biological; AID Autoimmun Diagnostika GmbH; Boditech Med Inc.; Oxford Immunotec (PerkinElmer); and Abbott Laboratories.

Polaris Market Research has segmented the latent TB testing market report on the basis of test type, application, end user, and region:

By Test Type Outlook (Volume, Number of Tests in Thousands; Revenue, USD Million, 2020-2034)

IGRA
TST

By Application Outlook (Volume, Number of Tests in Thousands; Revenue, USD Million, 2020-2034)

People Living with HIV
HHC with TB
Others

By End User Outlook (Volume, Number of Tests in Thousands; Revenue, USD Million, 2020-2034)

Diagnostic Laboratories
Hospitals & Clinics
Academic & Research Institutes
Others

By Regional Outlook (Volume, Number of Tests in Thousands; Revenue, USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

Product Code: PM5494

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Latent TB Testing Market Insights

4.1. Latent TB Testing Market - Market Snapshot
4.2. Latent TB Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Funding and Grants for TB Control Programs
  - 4.2.1.2. Rising Incidence of Latent TB
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Limited Access to Advanced Diagnostic Technologies in Low-Resource Settings
- 4.2.3. Public opinion and privacy legal precedents
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Latent TB Testing Market Trends
4.6. Value Chain Analysis

5. Global Latent TB Testing Market, by Test Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
5.3. IGRA
- 5.3.1. Global Latent TB Testing Market, by IGRA, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
5.4. TST
- 5.4.1. Global Latent TB Testing Market, by TST, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)

6. Global Latent TB Testing Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
6.3. People Living with HIV
- 6.3.1. Global Latent TB Testing Market, by People Living with HIV, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
6.4. HHC with TB
- 6.4.1. Global Latent TB Testing Market, by HHC with TB, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
6.5. Others
- 6.5.1. Global Latent TB Testing Market, by Others, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)

7. Global Latent TB Testing Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
7.3. Diagnostic Laboratories
- 7.3.1. Global Latent TB Testing Market, by Diagnostic Laboratories, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
7.4. Hospitals & Clinics
- 7.4.1. Global Latent TB Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
7.5. Academic & Research Institutes
- 7.5.1. Global Latent TB Testing Market, by Academic & Research Institutes, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
7.6. Others
- 7.6.1. Global Latent TB Testing Market, by Others, by Region, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)

8. Global Latent TB Testing Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Latent TB Testing Market Assessment, By Geography, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
8.3. Latent TB Testing Market - North America
- 8.3.1. North America: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.3.2. North America: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.3.3. North America: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.3.4. Latent TB Testing Market - US
  - 8.3.4.1. US: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.3.4.2. US: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.3.4.3. US: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.3.5. Latent TB Testing Market - Canada
  - 8.3.5.1. Canada: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.3.5.2. Canada: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.3.5.3. Canada: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
8.4. Latent TB Testing Market - Europe
- 8.4.1. Europe: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.2. Europe: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.3. Europe: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.4. Latent TB Testing Market - UK
  - 8.4.4.1. UK: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.4.2. UK: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.4.3. UK: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.5. Latent TB Testing Market - France
  - 8.4.5.1. France: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.5.2. France: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.5.3. France: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.6. Latent TB Testing Market - Germany
  - 8.4.6.1. Germany: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.6.2. Germany: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.6.3. Germany: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.7. Latent TB Testing Market - Italy
  - 8.4.7.1. Italy: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.7.2. Italy: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.7.3. Italy: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.8. Latent TB Testing Market - Spain
  - 8.4.8.1. Spain: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.8.2. Spain: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.8.3. Spain: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.9. Latent TB Testing Market - Netherlands
  - 8.4.9.1. Netherlands: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.9.2. Netherlands: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.9.3. Netherlands: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.10. Latent TB Testing Market - Russia
  - 8.4.10.1. Russia: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.10.2. Russia: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.10.3. Russia: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.4.11. Latent TB Testing Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.11.2. Rest of Europe: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.4.11.3. Rest of Europe: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
8.5. Latent TB Testing Market - Asia Pacific
- 8.5.1. Asia Pacific: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.2. Asia Pacific: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.3. Asia Pacific: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.4. Latent TB Testing Market - China
  - 8.5.4.1. China: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.4.2. China: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.4.3. China: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.5. Latent TB Testing Market - India
  - 8.5.5.1. India: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.5.2. India: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.5.3. India: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.6. Latent TB Testing Market - Malaysia
  - 8.5.6.1. Malaysia: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.6.2. Malaysia: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.6.3. Malaysia: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.7. Latent TB Testing Market - Japan
  - 8.5.7.1. Japan: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.7.2. Japan: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.7.3. Japan: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.8. Latent TB Testing Market - Indonesia
  - 8.5.8.1. Indonesia: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.8.2. Indonesia: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.8.3. Indonesia: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.9. Latent TB Testing Market - South Korea
  - 8.5.9.1. South Korea: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.9.2. South Korea: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.9.3. South Korea: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.10. Latent TB Testing Market - Australia
  - 8.5.10.1. Australia: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.10.2. Australia: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.10.3. Australia: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.5.11. Latent TB Testing Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
8.6. Latent TB Testing Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.6.2. Middle East & Africa: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.6.3. Middle East & Africa: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.6.4. Latent TB Testing Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.4.2. Saudi Arabia: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.4.3. Saudi Arabia: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.6.5. Latent TB Testing Market - UAE
  - 8.6.5.1. UAE: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.5.2. UAE: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.5.3. UAE: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.6.6. Latent TB Testing Market - Israel
  - 8.6.6.1. Israel: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.6.2. Israel: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.6.3. Israel: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.6.7. Latent TB Testing Market - South Africa
  - 8.6.7.1. South Africa: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.7.2. South Africa: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.7.3. South Africa: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.6.8. Latent TB Testing Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
8.7. Latent TB Testing Market - Latin America
- 8.7.1. Latin America: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.7.2. Latin America: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.7.3. Latin America: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.7.4. Latent TB Testing Market - Mexico
  - 8.7.4.1. Mexico: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.7.4.2. Mexico: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.7.4.3. Mexico: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.7.5. Latent TB Testing Market - Brazil
  - 8.7.5.1. Brazil: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.7.5.2. Brazil: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.7.5.3. Brazil: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.7.6. Latent TB Testing Market - Argentina
  - 8.7.6.1. Argentina: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.7.6.2. Argentina: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.7.6.3. Argentina: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
- 8.7.7. Latent TB Testing Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Latent TB Testing Market, by Test Type, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.7.7.2. Rest of Latin America: Latent TB Testing Market, by Application, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)
  - 8.7.7.3. Rest of Latin America: Latent TB Testing Market, by End User, 2020-2034 (Volume, Number of Tests in Thousands; USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. AID Autoimmun Diagnostika GmbH
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. ARKRAY, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Beijing Wantai Biopharmaceutical Co., Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. bioMerieux
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Boditech Med Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Endo, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Lionex GmbH
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Oxford Immunotec (PerkinElmer)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. QIAGEN
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Revvity
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Sanofi
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. SD Biosensor, INC.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Serum Institute of India Pvt. Ltd.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Zhi Fei Biological
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development